Johnson and Johnson Covid jab gets emergency use approvalWith this, Johnson and Johnson became third foreign-made vaccine to get nod after Sputnik V, Moderna; permission is only for imports of the...
08 Aug, 2021, 06.25 AM IST
Serum seeks nod for Covovax, J&J for its single-dose vaccineJohnson and Johnson (J&J) and Pune-based Serum Institute of India (SII) have applied to the drug regulator seeking emergency use authorisat...
07 Aug, 2021, 06.42 AM IST
Process to receive WHO pre-qualification for Covaxin on: GovtIn response to a question on when the WHO approval for Covaxin is expected, the minister said the data required for approval was submitted ...
20 Jul, 2021, 10.32 PM IST
Moderna's COVID-19 vaccine may soon get regulatory approval in IndiaModerna has also informed that the US Government has agreed to donate a certain number of doses of the Moderna COVID-19 vaccine through COV...
29 Jun, 2021, 02.20 PM IST
Pfizer, Moderna vaccines may soon be available in IndiaThe Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other inter...
02 Jun, 2021, 03.06 PM IST
Foreign produced COVID-19 vaccines: Decision on emergency use applications to be taken in 3 daysThe Central Drug Authority, CDSCO, will process applications for registration certificates (registration of overseas manufacturing site and...
16 Apr, 2021, 07.01 AM IST
Sun Pharma bullish on specialty biz, looks to expand the segment to new geographiesSharing information with shareholders, Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said the company's strategy of develo...
27 Sep, 2020, 10.51 AM IST
Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatmentStrides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...
29 Apr, 2020, 01.23 PM IST
Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in JapanMumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...
18 Jun, 2018, 11.59 AM IST
Lupin gets CDSCO nod for indigestion treatment tabletsAcotiamide is approved by Pharmaceuticals and Medical Devices Agency (PMDA) Japan and is actively marketed in Japan, it added.
22 Aug, 2016, 03.15 PM IST
Shilpa Medicare rallies 18% to break out from its 100 to 200-day moving averageThis development comes as a big relief to the company, especially at a time when many of the Indian pharma companies are trapped in regulat...
14 Apr, 2016, 03.47 AM IST
Shilpa Medicare zooms on receiving GMP certificate from Japan regulatorShilpa Medicare informed BSE that it has received good manufacturing practice (GMP) compliance certificate for two of its Karnataka-based A...
13 Apr, 2016, 03.54 PM IST
- Ind-Swift Labs Q3 PAT up 15.52 pc at Rs 28.44 cr
The company's profit after tax for the three months ended December 31, 2010 was Rs 24.62 crore, it said in a statement.
09 Feb, 2012, 03.17 PM IST
- Ind-Swift gets PMDA approval from Japan;stk up
Ind-Swift has got PMDA approval from Government of Japan for Pioglitazone and Risedronate Sodium to be manufactured at its facilities at De...
17 Feb, 2011, 03.06 PM IST
- Our consolidated topline is Rs 73 cr: Vishnukant Bhutada, MD, Shilpa Medicare
In an interaction with ET Now, Vishnukant Bhutada, Managing Director, Shilpa Medicare, analyses the company’s earnings figures & product ch...
27 Oct, 2010, 05.36 PM IST
- Daiichi sets up firm to market Ranbaxy products in Japan
Ranbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.
11 May, 2010, 08.19 PM IST
- Daiichi-Ranbaxy synergy plan delayed, announcement by Mar
Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo's proposal to unveil a three-year plan for exploiting synergies in operations t...
25 Feb, 2010, 09.37 PM IST